Search Results Search Sort by RelevanceMost Recent Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Case and Commentary Jul 2019 Should Aggregate Patient Preference Data Be Used to Make Decisions on Behalf of Unrepresented Patients? Nathaniel Sharadin, PhD, MA Ethical and practical problems with preference modeling can undermine how reliably predictors can be used in high-stakes decisions. AMA J Ethics. 2019;21(7):E566-574. doi: 10.1001/amajethics.2019.566. Case and Commentary Aug 2020 Do Physicians Have Collective, Not Just Individual, Obligations to Respond to the Opioid Crisis? Beth A. Lown, MD and Michael J. Goldberg, MD Mandating processes that are not evidence based generates distress among patients and clinicians, so physician advocacy in national, state, and local policymaking is key. AMA J Ethics. 2020;22(8):E668-674. doi: 10.1001/amajethics.2020.668. Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361. Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368. Case and Commentary Jun 2022 Should Children Be Enrolled in Clinical Research in Conflict Zones? Dónal O’Mathúna, PhD and Nawaraj Upadhaya, PhD Research that places subjects and investigators at risk of additional harm must be considered carefully. AMA J Ethics. 2022;24(6):E463-471. doi: 10.1001/amajethics.2022.463. Case and Commentary May 2022 ¿Cómo deberían responder los médicos al interés de los pacientes sobre suplementos dietético para tratar enfermedades crónicas graves? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES AMA J Ethics. 2022;E361-367. doi: 10.1001/amajethics.2022.361. Case and Commentary Jun 2022 هل يجب تسجيل الأطفال في الأبحاث السريرية في مناطق الصراع؟ Dónal O’Mathúna, PhD and Nawaraj Upadhaya, PhD AMA J Ethics. 2022;E463-471. doi: 10.1001/amajethics.2022.463. Case and Commentary Feb 2023 How Should Clinicians Minimize Bias When Responding to Suspicions About Child Abuse? Megan M. Letson, MD, MEd and Kristin G. Crichton, DO, MPH Following evidence-based approaches to evaluating and reporting suspicion of child maltreatment can help minimize bias and promote equity. AMA J Ethics. 2023;25(2):E93-99. doi: 10.1001/amajethics.2023.93. Case and Commentary Feb 2023 How Should Race and Resource Context Influence How Neglect Is Considered by Clinicians? David Kelly, JD, MA and Jerry Milner, DSW Separation of children from their parents is one possible traumatizing consequence of a mandated report, which is not to be taken lightly. AMA J Ethics. 2023;25(2):E100-108. doi: 10.1001/amajethics.2023.100. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Next page Next › Last page Last »
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
Case and Commentary Jul 2019 Should Aggregate Patient Preference Data Be Used to Make Decisions on Behalf of Unrepresented Patients? Nathaniel Sharadin, PhD, MA Ethical and practical problems with preference modeling can undermine how reliably predictors can be used in high-stakes decisions. AMA J Ethics. 2019;21(7):E566-574. doi: 10.1001/amajethics.2019.566.
Case and Commentary Aug 2020 Do Physicians Have Collective, Not Just Individual, Obligations to Respond to the Opioid Crisis? Beth A. Lown, MD and Michael J. Goldberg, MD Mandating processes that are not evidence based generates distress among patients and clinicians, so physician advocacy in national, state, and local policymaking is key. AMA J Ethics. 2020;22(8):E668-674. doi: 10.1001/amajethics.2020.668.
Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361.
Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368.
Case and Commentary Jun 2022 Should Children Be Enrolled in Clinical Research in Conflict Zones? Dónal O’Mathúna, PhD and Nawaraj Upadhaya, PhD Research that places subjects and investigators at risk of additional harm must be considered carefully. AMA J Ethics. 2022;24(6):E463-471. doi: 10.1001/amajethics.2022.463.
Case and Commentary May 2022 ¿Cómo deberían responder los médicos al interés de los pacientes sobre suplementos dietético para tratar enfermedades crónicas graves? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES AMA J Ethics. 2022;E361-367. doi: 10.1001/amajethics.2022.361.
Case and Commentary Jun 2022 هل يجب تسجيل الأطفال في الأبحاث السريرية في مناطق الصراع؟ Dónal O’Mathúna, PhD and Nawaraj Upadhaya, PhD AMA J Ethics. 2022;E463-471. doi: 10.1001/amajethics.2022.463.
Case and Commentary Feb 2023 How Should Clinicians Minimize Bias When Responding to Suspicions About Child Abuse? Megan M. Letson, MD, MEd and Kristin G. Crichton, DO, MPH Following evidence-based approaches to evaluating and reporting suspicion of child maltreatment can help minimize bias and promote equity. AMA J Ethics. 2023;25(2):E93-99. doi: 10.1001/amajethics.2023.93.
Case and Commentary Feb 2023 How Should Race and Resource Context Influence How Neglect Is Considered by Clinicians? David Kelly, JD, MA and Jerry Milner, DSW Separation of children from their parents is one possible traumatizing consequence of a mandated report, which is not to be taken lightly. AMA J Ethics. 2023;25(2):E100-108. doi: 10.1001/amajethics.2023.100.